drugset / Trial / NCT07687186

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

NCT07687186

Phase 3 Recruiting 636 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial will evaluate the efficacy and safety of Qishen Yiqi Dripping Pills in treatment of Chronic Heart Failure with reduced ejection fraction resorted from Coronary Heart Disease (Syndrome of Qi Deficiency with Blood Stasis).

Timeline

Start
2026-06-22
Primary completion
2028-06-22
Completion
2028-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Qishen Yiqi dripping pills Traditional medicine (herbal / TCM) 1.04 g Oral

Indications